Robert Brown

6PUBLICATIONS
57CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 01, 2025
Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients.

Muhammad Habiburrahman, Nahal Masrour, Naina Patel

|Feb 08, 2022
Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma.

Pavlina Spiliopoulou, Sarah Spear, Hasan Mirza

|Jun 06, 2021
Chromatin accessibility changes at intergenic regions are associated with ovarian cancer drug resistance.

John Gallon, Erick Loomis, Edward Curry

|Mar 12, 2021
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer.

Michal M Hoppe, Patrick Jaynes, Joanna D Wardyn

|Jan 13, 2021
Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression.

Marina Natoli, John Gallon, Haonan Lu

|Jun 20, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Aline Talhouk, Joshy George, Chen Wang

Pageof 1

Frequent Collaborators

3 joint publications

Iain A McNeish

2 joint publications

Marina Natoli

2 joint publications

James D Brenton

2 joint publications

Tuan Zea Tan